Contact
searchSearch
HMP Global

News

News
AHA Statement Finds Few With Diabetes Reduce Heart Disease Risk
01/10/2022
The statement addresses the gap between existing evidence on how best to lower cardiovascular disease (CVD) risk in people with Type 2 diabetes and the reality for people living with the disease. 
The statement addresses the gap between existing evidence on how best to lower cardiovascular disease (CVD) risk in people with Type 2 diabetes and the reality for people living with the disease. 
The statement addresses the gap...
01/10/2022
Cath Lab Digest
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Heart Failure Prevalence Among US Nursing Home Residents With Diabetes Mellitus
12/03/2021
Authors of a recent study explored the prevalence of heart failure among nursing home residents who also have diabetes mellitus and note that future research is needed to understand how multiple comorbid conditions affect this patient...
Authors of a recent study explored the prevalence of heart failure among nursing home residents who also have diabetes mellitus and note that future research is needed to understand how multiple comorbid conditions affect this patient...
Authors of a recent study...
12/03/2021
Annals of Long-Term Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
Screening for Polycystic Ovary Syndrome in Women With Acne
09/14/2021
Patients with adult female acne of a younger age, with premenstrual flares of acne, and irregular menstruation should be screened for polycystic ovary syndrome.
Patients with adult female acne of a younger age, with premenstrual flares of acne, and irregular menstruation should be screened for polycystic ovary syndrome.
Patients with adult female acne...
09/14/2021
The Dermatologist
News
Rate of Hypothyroidism is High in Patients With Rosacea
08/06/2021
Rates of hypothyroidism are higher in patients with rosacea compared with a control group, according to a recent study published in Anais Brasileiros de Dermatologia.
Rates of hypothyroidism are higher in patients with rosacea compared with a control group, according to a recent study published in Anais Brasileiros de Dermatologia.
Rates of hypothyroidism are...
08/06/2021
The Dermatologist
News
Maternal Hypothyroidism Boosts ADHD Risk
10/26/2020
Maternal hypothyroidism in early pregnancy significantly raises the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a published study.
Maternal hypothyroidism in early pregnancy significantly raises the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a published study.
Maternal hypothyroidism in early...
10/26/2020
Psych Congress Network
News
ESC: Young Women With Polycystic Ovary Syndrome Have Raised Risk of Heart Disease
08/03/2020
Sophia Antipolis – 3 August
Sophia Antipolis – 3 August
Sophia Antipolis – 3 August
08/03/2020
Cath Lab Digest
News
Polycystic Ovarian Syndrome: So Much More Than Infertility
04/16/2020
Through patient education, expanding awareness, and continuing investigation into the complexities of this syndrome, the millions of women affected by PCOS can enhance their health and overall quality of life and possibly reduce or prevent...
Through patient education, expanding awareness, and continuing investigation into the complexities of this syndrome, the millions of women affected by PCOS can enhance their health and overall quality of life and possibly reduce or prevent...
Through patient education,...
04/16/2020
Pharmacy Learning Network
News
Is Hypothyroidism Tied to Mortality in OAs?
12/12/2019
“Based on the current evidence, hypothyroidism is significantly associated with increased all-cause mortality instead of cardiovascular mortality among the elderly,” researchers of a study concluded.
“Based on the current evidence, hypothyroidism is significantly associated with increased all-cause mortality instead of cardiovascular mortality among the elderly,” researchers of a study concluded.
“Based on the current evidence,...
12/12/2019
Annals of Long-Term Care

In the News

News
First Allogeneic Pancreatic Islet Cellular Therapy Is Approved for Type 1 Diabetes
06/28/2023
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new...
06/28/2023
Endocrinology & Diabetes
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Veradigm and HealthVerity Collaborate to Advance Real-World Evidence and Care for Patients with Cardiovascular Disease and Diabetes
02/13/2023
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of...
02/13/2023
EP Lab Digest
News
Assessing Bone Health in Long-term Care Residents With Diabetes
01/04/2023
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using...
01/04/2023
Annals of Long-Term Care
News
Complex Medication Regimens Associated With Poorer Type 2 Diabetes Outcomes
01/03/2023
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
Does New-Onset Diabetes Predict Pancreatic Cancer?
01/02/2023
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals...
01/02/2023
Gastroenterology
News
Study Observes Damage to Thyroid Gland in Fatal Burn Patients
09/07/2022
A recent histopathological study confirmed follicular distortion of the thyroid gland in medicolegal autopsy of 64 patients who suffered fatal burn wounds, highlighting the possible benefit of thyroid hormone supplementation in burn patients.
A recent histopathological study confirmed follicular distortion of the thyroid gland in medicolegal autopsy of 64 patients who suffered fatal burn wounds, highlighting the possible benefit of thyroid hormone supplementation in burn patients.
A recent histopathological study...
09/07/2022
Wound Care
News
Thyroid, Growth Hormones in Children Unaffected by 1 Year of Low-Dose ADHD Drugs
05/02/2022
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage...
05/02/2022
Psych Congress Network
Diabetes Watch
Examining The Expanding Clinical Benefits Linked With Metformin Use
01/26/2022
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author...
01/26/2022
Podiatry Today
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use